Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Other Non-Current Liabilities of $61.9 million for Q1 2026, down 2.28% year-over-year from $63.3 million in Q1 2025, and up 1.94% quarter-over-quarter from $60.7 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Other Non-Current Liabilities for 7 consecutive years, with $61.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 2.28% year-over-year to $61.9 million; the TTM figure through Mar 2026 stood at $61.9 million (down 2.28% YoY), while the FY2025 annual figure was $60.7 million, up 190.61% from the prior year.
- Other Non-Current Liabilities grew to $61.9 million in Q1 2026 per STVN's latest filing, from $60.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $64.5 million in Q3 2025 and bottomed at -$67.0 million in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $28.2 million across 5 years, with a median of $55.3 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 796.8% — and 2023, when it soared 1798.68%.
- Stevanato Group S.p.A's Other Non-Current Liabilities stood at -$18.5 million in 2022, then sank by 182.58% to -$52.2 million in 2023, then retreated by 28.4% to -$67.0 million in 2024, then jumped by 190.61% to $60.7 million in 2025, then climbed by 1.94% to $61.9 million in 2026.
- Business Quant data shows STVN's Other Non-Current Liabilities at $61.9 million in Q1 2026, $60.7 million in Q4 2025, and $64.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.86 Mn |
| Mar 31, 2026 | 61.89 Mn |
| Dec 31, 2025 | 60.71 Mn |
| Sep 30, 2025 | 64.48 Mn |
| Jun 30, 2025 | 62.93 Mn |
| Mar 31, 2025 | 63.33 Mn |
| Dec 31, 2024 | -67.00 Mn |
| Sep 30, 2024 | 57.29 Mn |
| Jun 30, 2024 | 55.29 Mn |
| Mar 31, 2024 | 55.28 Mn |
| Dec 31, 2023 | -52.18 Mn |
| Sep 30, 2023 | 56.68 Mn |
| Jun 30, 2023 | 36.97 Mn |
| Mar 31, 2023 | 22.25 Mn |
| Dec 31, 2022 | -18.47 Mn |
| Sep 30, 2022 | 16.13 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | -2.12 Mn |